DEC 01, 2020 5:39 AM PST

The price tag of prostate cancer treatment

New research published in The Journal of Urology from the Official Journal of the American Urological Association (AUA) reports on the price tag associated with prostate cancer in men. The study contemplates the financial toxicity of cancer care, referring to the “the distress or hardship experienced by patients due to the cost of cancer treatment."

Men diagnosed with localized prostate cancer have a choice of treatment options: active surveillance, radiation, or surgery. Too little attention has been given to analyzing the financial influence behind a patient’s decision-making process. Given that certain treatments carry different price tags, senior author Daniel A. Barocas, MD, MPH says: "Cost of treatment and the associated financial burden could be an important factor in treatment decisions.”

As one of the most common cancers in men, it is crucial to dig deeper into the financial side of cancer treatment. To investigate the relationship between financial burdens and treatment choice, the researchers analyzed data on 2,121 patients, comparing the financial burdens for patients choosing surgery (radical prostatectomy), external beam radiation therapy (EBRT), or active surveillance.

The findings were clear: "Our research shows radiation therapy seems to have the highest financial burden for patients with clinically localized prostate cancer, compared to surgery or active surveillance," says lead author Benjamin V. Stone, MD. "However, our study also shows there is a relatively small percentage of patients who experience a large or very large financial burden due to treatment, and the financial burden lessens over time."

This is evidenced by the response given by 15% of patients who reported experiencing "a large or very large" burden of treatment costs in the first six months following treatment. Meanwhile, 11% of patients who underwent EBRT reported financial toxicity.

Photo: Pexels

"Overall, our follow-up study suggests that radiation therapy has a longer-lasting burden of costs, compared to other initial treatment options for prostate cancer," the researchers state. They add that "The association of financial burden with socioeconomic factors such as race and education is in line with the results of previous studies in the United States and worldwide," Drs. Stone and Barocas and coauthors write.

Sources: The Journal of Urology, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 18, 2021
Cancer
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
JAN 18, 2021
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
Breast cancer is one of the most well-studied cancers in modern medicine. Diagnostics can already differentiate between ...
JAN 26, 2021
Cancer
Proposed intervention aims to reduce heart damage from chemotherapy drug
JAN 26, 2021
Proposed intervention aims to reduce heart damage from chemotherapy drug
Experiments conducted in cell cultures and mice models provide evidence for the effectiveness of a new intervention to p ...
JAN 31, 2021
Genetics & Genomics
Targeting Aneuploidy in Cancer Cells
JAN 31, 2021
Targeting Aneuploidy in Cancer Cells
Cancer is typically related to problems in cells' genomes that lead to uncontrolled cell growth, and the formation of tu ...
FEB 17, 2021
Clinical & Molecular DX
Urine Test Bypasses the Need for Prostate Biopsies
FEB 17, 2021
Urine Test Bypasses the Need for Prostate Biopsies
Researchers have created a urine test for prostate cancer that could make unnecessary biopsies a thing of the past. The ...
APR 03, 2021
Drug Discovery & Development
Why Are Some Cancer Therapeutics Ineffective?
APR 03, 2021
Why Are Some Cancer Therapeutics Ineffective?
Why don’t some cancer therapeutics not work in humans when they were successful in mice? The answer to this questi ...
APR 08, 2021
Cancer
What can modifiying cultured cells to act more like normal cells teach us about cancer?
APR 08, 2021
What can modifiying cultured cells to act more like normal cells teach us about cancer?
A team from the University of Louisville has developed a technique to make cell cultures act more like normal cells. Thi ...
Loading Comments...